Innovative aptamer approaches in glial tumor diagnostics and therapy: Progress and future directions

Area of Science:

• Neuro-oncology
• Biotechnology
• Molecular Medicine

Background:

• Glial tumors, especially glioblastomas, are difficult to treat due to tumor complexity and the blood-brain barrier.
• Conventional treatments face challenges in drug delivery and specificity.

Purpose of the Study:

• To review recent advancements in aptamer technology for glial brain tumor diagnosis and treatment.
• To highlight the potential of aptamers in overcoming current therapeutic and diagnostic limitations.

Main Methods:

• Review of current literature on aptamer applications in neuro-oncology.
• Focus on aptamer use in molecular imaging, liquid biopsy, and targeted drug delivery.
• Exploration of aptamer integration with nanotechnology and artificial intelligence (AI).

Main Results:

• Aptamers demonstrate high specificity, low immunogenicity, and enhanced tissue penetration for glial tumors.
• Applications include molecular imaging, liquid biopsy, intraoperative visualization, and targeted delivery of therapeutics (siRNAs, small molecules, immunomodulators).
• Integration with nanotechnology and AI is enabling sensitive, non-invasive diagnostic tools and theranostic platforms.

Conclusions:

• Aptamers represent a significant advancement in neuro-oncology, offering versatile solutions for glial brain tumor management.
• Future directions involve developing sophisticated aptamer-based theranostic systems for improved patient outcomes.